BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15864887)

  • 1. Anaphylaxis produced by oxaliplatin.
    González-Mahave I; Lobera Iabairu T; Blasco Sarramián A; del Pozo Gil MD; Zorrilla M; Vélez de Mendizábal E
    J Investig Allergol Clin Immunol; 2005; 15(1):75-7. PubMed ID: 15864887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe anaphylactic reactions to oxaliplatin.
    Tournigand C; Maindrault-Goebel F; Louvet C; de Gramont A; Krulik M
    Eur J Cancer; 1998 Jul; 34(8):1297-8. PubMed ID: 9849497
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe anaphylactic reaction to oxaliplatin.
    Alliot C; Messouak D; Beets C; Rapin JP
    Clin Oncol (R Coll Radiol); 2001; 13(3):236. PubMed ID: 11527302
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxaliplatin-induced immune mediated thrombocytopenia.
    Beg MS; Komrokji RS; Ahmed K; Safa MM
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
    Gammon D; Bhargava P; McCormick MJ
    Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
    Bhargava P; Gammon D; McCormick MJ
    Cancer; 2004 Jan; 100(1):211-2. PubMed ID: 14692042
    [No Abstract]   [Full Text] [Related]  

  • 7. Desensitizing oxaliplatin-induced fever: a case report.
    Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Guillen-Ponce C; Sanz ML; Alvarez-Cuesta E
    J Investig Allergol Clin Immunol; 2013; 23(6):435-6. PubMed ID: 24459821
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed urticaria with oxaliplatin.
    Villée C; Tennstedt D; Marot L; Goossens A; Baeck M
    Contact Dermatitis; 2010 Jul; 63(1):50-3. PubMed ID: 20597935
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent priapism related to oxaliplatin infusion.
    Adenis A; Mailliez A; Rigot JM; Gamelin L; Vanhuyse M; Gamelin E
    J Clin Oncol; 2008 Feb; 26(6):1016-7. PubMed ID: 18281680
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxaliplatin-induced Evan's syndrome.
    Earle CC; Chen WY; Ryan DP; Mayer RJ
    Br J Cancer; 2001 Feb; 84(3):441. PubMed ID: 11161414
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal oxaliplatin-induced thrombotic thrombocytopenic purpura: a case report.
    Baretta Z; Falci C; Piva E; Conte P
    Clin Colorectal Cancer; 2013 Dec; 12(4):294-6. PubMed ID: 24188688
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunoallergic shock to oxaliplatin: a new case].
    Cournède A; Ries P; Dahan L; Richard K; Grandval P; Braguer D; Seitz JF
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):665-6. PubMed ID: 12910238
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis].
    Junker A; Kretzschmar A; Böhm U; Tannapfel A; Langenbahn D; Pieck AC; Jaehde U
    Med Monatsschr Pharm; 2004 Oct; 27(10):349-52. PubMed ID: 15527179
    [No Abstract]   [Full Text] [Related]  

  • 14. Anaphylaxis after oxaliplatin allergy skin testing.
    Martin-Lazaro J; Firvida JL; Berges-Gimeno P
    J Investig Allergol Clin Immunol; 2014; 24(4):269-70. PubMed ID: 25219110
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule.
    Meyer L; Zuberbier T; Worm M; Oettle H; Riess H
    J Clin Oncol; 2002 Feb; 20(4):1146-7. PubMed ID: 11844841
    [No Abstract]   [Full Text] [Related]  

  • 16. Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report.
    Santodirocco M; Lombardi V; Fesce C; Palumbo G; Capalbo S; Landriscina M
    Acta Oncol; 2008; 47(8):1602-4. PubMed ID: 18607839
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxaliplatin hypersensitivity complicated by thrombocytopenia during desensitization.
    Tuttle KL; Stavrou E; Hong DIC; Connell NT; Wickner P
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):267-269. PubMed ID: 33971363
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohemolytic anemia following oxaliplatin administration.
    Garufi C; Vaglio S; Brienza S; Conti L; D'Attino RM; Girelli G; Terzoli E
    Ann Oncol; 2000 Apr; 11(4):497. PubMed ID: 10847475
    [No Abstract]   [Full Text] [Related]  

  • 19. Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients.
    Maindrault-Goebel F; André T; Tournigand C; Louvet C; Perez-Staub N; Zeghib N; De Gramont A
    Eur J Cancer; 2005 Oct; 41(15):2262-7. PubMed ID: 16154353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.
    Pagani M; Bonadonna P; Senna GE; Antico A
    Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.